Medicine News and Research

RSS

Singapore to become a major hub in Asia for food and nutrition research

The Clinical Nutrition Research Centre - a $20 million joint-venture by the Agency for Science, Technology and Research and National University Health Systems - is the most comprehensive centre in Asia that will conduct nutritional studies to understand the causes of metabolic diseases such as diabetes and obesity, and develop products and formulate diets that can reduce the risks of these diseases. CNRC will also conduct studies in research areas such as nutrition in women, children and the elderly, and body weight control.

30 Jan 2014

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received new awards from the California Institute of Regenerative Medicine (CIRM), the state stem cell research agency, that will forward revolutionary stem cell science in medicine.

30 Jan 2014

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.

30 Jan 2014

Spontaneous tumorigenic transformation of human MSCs can occur during cell culture expansion

Researchers at Erasmus University Medical Center Rotterdam, The Netherlands, led by Dr. Qiuwei Pan and Dr. Luc van der Laan, have discovered that spontaneous tumorigenic transformation of human mesenchymal stem/stromal cells (MSCs) can occur during cell culture expansion, although the frequency is relatively low and often only observed after extensive passage in culture.

30 Jan 2014

State highlights: Will doc cuts like those in Conn. become more common?; Calif. health plans criticized over chronic condition treatment; Vt. drug addiction

A selection of health policy stories from Connecticut, California, Vermont, Minnesota, Virginia and Georgia.

30 Jan 2014

University of Liverpool receives funding to continue reducing impact of adverse reactions to medicinal drugs

The Medical Research Council (MRC) Centre for Drug Safety Science at the University of Liverpool has received three million pounds of new funding from MRC to allow it to continue reducing the impact of adverse reactions to medicinal drugs.

30 Jan 2014

Findings on molecular defects behind bladder cancer may pave way for new, targeted treatments

The once sketchy landscape of the molecular defects behind bladder cancer now resembles a road map to new, targeted treatments thanks to the unified efforts of scientists and physicians at 40 institutions.

30 Jan 2014

Johnson & Johnson enters into novel agreement with YODA to share clinical trials data

Johnson & Johnson today announced that its subsidiary, Janssen Research and Development, LLC, has entered into a novel agreement with Yale School of Medicine's Open Data Access (YODA) Project that will extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine.

30 Jan 2014

Exposure to DDT may increase likelihood of developing Alzheimer's disease later in life

Exposure to DDT may increase the likelihood of developing Alzheimer's disease later in life, a study with researchers at UT Southwestern Medical Center suggests. While previous studies have linked chronic diseases such as cancer and diabetes to DDT, this is the first clinical study to link the U.S.-banned pesticide to Alzheimer's disease.

30 Jan 2014

Johns Hopkins researchers discover epilepsy drug reduces obesity-related blood sugar levels

Johns Hopkins researchers have discovered that valproic acid, a widely prescribed drug for treating epilepsy, has the additional benefits of reducing fat accumulation in the liver and lowering blood sugar levels in the blood of obese mice.

30 Jan 2014

Vaccine to treat precancerous cervical lesions triggers immune cell response

Preliminary results of a small clinical trial show that a vaccine used to treat women with high-grade precancerous cervical lesions triggers an immune cell response within the damaged tissue itself.

30 Jan 2014

Mammography beneficial for women in their 40s, find researchers

Researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine have published new findings in the February issue of American Journal of Roentgenology that mammography remains beneficial for women in their 40s.

30 Jan 2014

Study details about healthful compounds contained in hempseed

Long stigmatized because of its "high"-inducing cousins, hemp - derived from low-hallucinogenic varieties of cannabis - is making a comeback, not just as a source of fiber for textiles, but also as a crop packed with oils that have potential health benefits.

30 Jan 2014

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.

29 Jan 2014

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

While ultrasound provides a less expensive and radiation-free alternative to detecting and monitoring cancer compared to technologies such as X-rays, CT scans, and MRIs, ultrasound has seen limited use in cancer treatment due to clarity and resolution issues.

29 Jan 2014

Impaired cognitive insight linked to delusions in psychosis risk

High levels of self-certainty, one aspect of cognitive insight, are associated with the presence of delusional symptoms in people with at-risk mental states, a study shows.

29 Jan 2014

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Omeros Corporation today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients with schizophrenia. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases that affect cognition, including schizophrenia and Huntington's disease.

29 Jan 2014

Study outlines agenda to help direct future caffeine dependence research

"I'm a zombie without my morning coffee." "My blood type is Diet Coke." "Caffeine isn't a drug, it's a vitamin." Most people make jokes like these about needing a daily boost from their favorite caffeinated beverage-whether first thing in the morning or to prevent the after-lunch slump.

29 Jan 2014

CCSC identifies 5 routine practices for multidisciplinary teams of critical care professionals

The American Association of Critical-Care Nurses (AACN) — as part of the Critical Care Societies Collaborative (CCSC) — has identified five routine critical care practices that should be questioned because they may not always be necessary and could, in fact, be harmful.

29 Jan 2014

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

NPS MedicineWise is urging all health professionals to take the pledge to fight antibiotic resistance after new research shows that making a public commitment leads to significant improvements in antibiotic prescribing.

29 Jan 2014

Medicine News and Research

Singapore to become a major hub in Asia for food and nutrition research

Scientists receive new awards from CIRM to advance revolutionary stem cell science in medicine

TCGA Research Network identify new potential therapeutic targets for major form of bladder cancer

Spontaneous tumorigenic transformation of human MSCs can occur during cell culture expansion

State highlights: Will doc cuts like those in Conn. become more common?; Calif. health plans criticized over chronic condition treatment; Vt. drug addiction

University of Liverpool receives funding to continue reducing impact of adverse reactions to medicinal drugs

Findings on molecular defects behind bladder cancer may pave way for new, targeted treatments

Johnson & Johnson enters into novel agreement with YODA to share clinical trials data

Exposure to DDT may increase likelihood of developing Alzheimer's disease later in life

Johns Hopkins researchers discover epilepsy drug reduces obesity-related blood sugar levels

Vaccine to treat precancerous cervical lesions triggers immune cell response

Mammography beneficial for women in their 40s, find researchers

Study details about healthful compounds contained in hempseed

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

UNC researchers develop new radiation-free ultrasound technique to detect, monitor cancer

Impaired cognitive insight linked to delusions in psychosis risk

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Study outlines agenda to help direct future caffeine dependence research

CCSC identifies 5 routine practices for multidisciplinary teams of critical care professionals

NPS MedicineWise urges health professionals to take the pledge to fight antibiotic resistance

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News